Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 12
2015 14
2016 8
2017 6
2018 4
2019 7
2020 8
2021 7
2022 5
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Accuracy Is Everything?
Ginter PS, Hoda SA. Ginter PS, et al. Am J Clin Pathol. 2021 Aug 4;156(3):331-333. doi: 10.1093/ajcp/aqaa232. Am J Clin Pathol. 2021. PMID: 33899082 No abstract available.
Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.
Rodrigues G, Hoshino A, Kenific CM, Matei IR, Steiner L, Freitas D, Kim HS, Oxley PR, Scandariato I, Casanova-Salas I, Dai J, Badwe CR, Gril B, Tešić Mark M, Dill BD, Molina H, Zhang H, Benito-Martin A, Bojmar L, Ararso Y, Offer K, LaPlant Q, Buehring W, Wang H, Jiang X, Lu TM, Liu Y, Sabari JK, Shin SJ, Narula N, Ginter PS, Rajasekhar VK, Healey JH, Meylan E, Costa-Silva B, Wang SE, Rafii S, Altorki NK, Rudin CM, Jones DR, Steeg PS, Peinado H, Ghajar CM, Bromberg J, de Sousa M, Pisapia D, Lyden D. Rodrigues G, et al. Among authors: ginter ps. Nat Cell Biol. 2019 Nov;21(11):1403-1412. doi: 10.1038/s41556-019-0404-4. Epub 2019 Nov 4. Nat Cell Biol. 2019. PMID: 31685984 Free PMC article.
A review of mucinous lesions of the breast.
Ginter PS, Tang X, Shin SJ. Ginter PS, et al. Breast J. 2020 Jun;26(6):1168-1178. doi: 10.1111/tbj.13878. Epub 2020 May 18. Breast J. 2020. PMID: 32419267 Review.
Mammary Lymphangioma.
Arafah M, Sweet G, Ginter PS, Hoda SA. Arafah M, et al. Among authors: ginter ps. Int J Surg Pathol. 2015 Oct;23(7):542-3. doi: 10.1177/1066896915593800. Epub 2015 Jul 1. Int J Surg Pathol. 2015. PMID: 26135530 No abstract available.
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Madorsky Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Altorki NK, Cheng E, Ginter PS, Hoda S, Newman L, Elemento O, Olopade OI, Davis MB, Martin ML, Bargonetti J. Madorsky Rowdo FP, et al. Among authors: ginter ps. Cancer Lett. 2024 Mar 1;584:216608. doi: 10.1016/j.canlet.2024.216608. Epub 2024 Jan 9. Cancer Lett. 2024. PMID: 38199587 Free article.
Recognition Awards in Pathology Specialty Societies.
Wobker SE, Ginter PS, Parra-Herran C, Schwartz LE, Booth GS, Fitzhugh VA, Silver JK, Khani F. Wobker SE, et al. Among authors: ginter ps. Am J Clin Pathol. 2022 Oct 6;158(4):499-505. doi: 10.1093/ajcp/aqac076. Am J Clin Pathol. 2022. PMID: 35932465
Subareolar Sclerosing Ductal Hyperplasia.
Cheng E, D'Alfonso TM, Arafah M, Marrero Rolon R, Ginter PS, Hoda SA. Cheng E, et al. Among authors: ginter ps. Int J Surg Pathol. 2017 Feb;25(1):4-11. doi: 10.1177/1066896916677288. Epub 2016 Nov 10. Int J Surg Pathol. 2017. PMID: 27831531
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy.
Kim G, Karadal-Ferrena B, Qin J, Sharma VP, Oktay IS, Lin Y, Ye X, Asiry S, Pastoriza JM, Cheng E, Ladak N, Condeelis JS, Adler E, Ginter PS, D'Alfonso T, Entenberg D, Xue X, Sparano JA, Oktay MH. Kim G, et al. Among authors: ginter ps. NPJ Breast Cancer. 2023 Jun 13;9(1):52. doi: 10.1038/s41523-023-00547-w. NPJ Breast Cancer. 2023. PMID: 37311792 Free PMC article.
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Madorsky Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Olopade OI, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Altorki NK, Cheng E, Ginter PS, Hoda S, Newman L, Elemento O, Davis MB, Martin ML, Bargonetti J. Madorsky Rowdo FP, et al. Among authors: ginter ps. bioRxiv [Preprint]. 2023 Jun 22:2023.06.22.544406. doi: 10.1101/2023.06.22.544406. bioRxiv. 2023. PMID: 38076873 Free PMC article. Updated. Preprint.
64 results